APA

Buyon J. P., Shadick N., Berkman R., Hopkins P., Dalton J., Weissmann G., Winchester R. & Abramson S. B. (19880217). Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus. : Clinical immunology and immunopathology.

Chicago

Buyon J P, Shadick N, Berkman R, Hopkins P, Dalton J, Weissmann G, Winchester R and Abramson S B. 19880217. Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus. : Clinical immunology and immunopathology.

Harvard

Buyon J. P., Shadick N., Berkman R., Hopkins P., Dalton J., Weissmann G., Winchester R. and Abramson S. B. (19880217). Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus. : Clinical immunology and immunopathology.

MLA

Buyon J P, Shadick N, Berkman R, Hopkins P, Dalton J, Weissmann G, Winchester R and Abramson S B. Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus. : Clinical immunology and immunopathology. 19880217.